معرفی
Mojdeh Abbasi is a Research Focused Academic at the Save Sight Institute within the Faculty of Medicine and Health at the University of Sydney. Her research primarily explores mechanisms underlying glaucoma, retinal neurodegeneration, and caveolin signaling pathways. Key areas of focus include neuroprotective strategies, molecular biology of ocular diseases, and translational therapies.
Her work combines experimental models (e.g., murine glaucoma models) with advanced techniques such as proteomics and gene therapy. Recent studies investigate the role of PAX6 in corneal repair, miRNA modulation in genetic ocular disorders, and the therapeutic potential of compounds like duloxetine. Collaborations involve interdisciplinary approaches to bridge basic science and clinical applications.
Publications span Theranostics, Molecular Neurobiology, and Gene Reports, reflecting contributions to understanding caveolin-1’s role in retinal injury and Shp2’s involvement in endoplasmic reticulum stress. While no formal awards are listed, her work is cited in contexts like corneal stem cell identity and glaucoma pathogenesis.
Research extends to biomarker discovery (e.g., procoagulant microvesicles in sickle cell disease) and material science (graphene composites under dynamic loads). No formal student advising roles or grants are explicitly detailed in available texts.
Labs and teams include the Save Sight Institute’s ocular research groups, focusing on translational ophthalmology and molecular mechanisms of eye diseases. Future work aims to advance therapies targeting caveolin signaling and neurotrophic pathways in retinal protection.
